Search

Your search keyword '"Kanhaiya L. Poddar"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Kanhaiya L. Poddar" Remove constraint Author: "Kanhaiya L. Poddar" Topic in patient Remove constraint Topic: in patient
56 results on '"Kanhaiya L. Poddar"'

Search Results

1. Meta-Analysis of Usefulness of Anticoagulation After Transcatheter Aortic Valve Implantation

2. Risk of Cerebrovascular Events in Patients With Patent Foramen Ovale and Intracardiac Devices

3. TCT-652 Outcomes in Patients with Transcatheter Aortic Valve Replacement and Left Main Stent: The multicenter, multinational TAVR-LM Registry

4. USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING

5. 'Smoker's paradox' in young patients with acute myocardial infarction

6. HIGH LOADING DOSE (600 MG) VERSUS INTERMEDIATE LOADING DOSE (450 MG) OF CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS IN ASIAN POPULATION

7. Prevalence and Outcomes of Unoperated Patients With Severe Symptomatic Mitral Regurgitation and Heart Failure

8. Letter by Lin et al Regarding Article, 'Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention'

9. AS-074 Two-Year Clinical Efficacy of Rosuvastatin Compared with Other Potent Statins in Patients Undergoing Percutaneous Coronary Intervesion with Drug Eluting Stents

10. AS-191 Clinical and Angiographic Characteristics of Coronary Endothelial Dysfunction Severity in Patients with Myocardial Bridge as assessed by Acetylcholine Provocation Test

11. AS-216 Impact of Prior History of Cerebral Infarction versus Intracerebral Hemorrhage on Clinical Outcomes in Patients Undergoing Percutanoeus Coronary Intervention with Drug-Eluting Stents

12. AS-159 High Loading Dose (600mg) versus Intermediate Loading Dose (450mg) of Clopidogrel in Patients undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents in Asian Population

13. AS-161 Intermediate Loading Dose (450mg) versus Standard Loading Dose (300mg) of Clopidogrel in Patients undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents in Asian Population

14. AS-91: The Influence of Previous Myocardial Infarction on 12-Month Clinical Outcomes in Patients with Recurrent Acute Myocardial Infarction

15. AS-259: Safety and Efficacy of Adjunctive Cilostazol in Patients with Left Main Disease Undergoing Percutaneous Coronary Intervention with Drug Eluting Stent

16. AS-95: Propensity Score Analysis of 12-Month Clinical Outcomes After Pitavastatin (Livalo) Administration in Patients with Acute Myocardial Infarction: Results from the Livalo Acute Myocardial Infarction Study (LAMIS)

17. AS-207: Impact of Serum Fibrinogen Level on In-Hospital Outcomes in Patients Undergoing Percutenous Coronary Interventions with Drug-Eluting Stent

18. AS-108: Pitavastatin (Livalo) Versus No Statins in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: 12-Month Clinical Outcomes from the Livalo Acute Myocardial Infarction Study (LAMIS)

19. AS-261: Midterm Clinical Course following Optimal Medical Therapy and Characteristics of Combined Disease in Patients with Vasospastic Angina

20. AS-162: Main Branch versus Side Branch Stenting Using Small Drug-Eluting Stents in Patients with Small Coronary Lesions

21. AS-165: Impact of Calcified versus Nonsignificantly Calcified Coronary Lesions on Midterm Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

22. AS-85: Early and Midterm Clinical Outcomes of Single versus Multiple Lesions in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-eluting Stent

23. AS-135 Incidence of Tachyarrhythmia and its Impact on Two-Year Clinical Outcomes in Patients with ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

24. AS-215 Impact of ApoB/ApoA-I Ratio on One-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

25. AS-206 Uric Acid and Hemoglobin Level; Novel Risk Predictors of Acute Kidney Injury in Patient Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

26. CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS OF CORONARY ENDOTHELIAL DYSFUNCTION SEVERITY IN PATIENTS WITH MYOCARDIAL BRIDGE AS ASSESSED BY ACETYLCHOLINE PROVOCATION TEST

27. AS-225 Lipoprotein(a) level and One-Year Clinical Outcome in Patients in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

28. AS-190 Different Clinical Characteristics of Focal versus Diffuse Coronary Endothelial Dysfunction in Patients with Myocardial Bridge

29. AS-151 Comparison of Long Term Clinical Outcomes in patients with STEMI and Single Vessel Disease undergoing Percutaneous Coronary Intervention in DES Era

30. AS-243 Is the Prognosis of Octogenarians Worse as compared with Non-Octogenarians in Patients Undergoing Percutaneous Coronary Interventions in Drug-Eluting Stent Era?

31. INCIDENCE OF TACHYARRHYTHMIA AND ITS IMPACT ON TWO-YEAR CLINICAL OUTCOMES IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS

32. AS-196: Acetylcholine-Induced Coronary Artery Spasm in Patients Treated with Drug-Eluting Stents is Different from De Novo Coronary Artery Spasm: Insights from Immediate Results and 12-Month Clinical Outcomes

33. AS-83: Impact of Statin on 12-Month Clinical Outcomes in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

34. AS-194: Influence of Acetylcholine Provocation Test Results on 12-Month Clinical Outcomes in Patients Treated with Drug-Eluting Stents in Asian Population

35. AS-258: Impact of Adjunctive Cilostazol in Preventing Postprocedural Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

36. AS-245: Novel Infrapopliteal Artery Intervention Technique Using 5-Fr Heartrail Catheter with Coronary Balloon System in Patients with Critical Limb Ischemia

37. AS-90: The Influence of Previous Myocardial Infarction on 12-Month Clinical Outcomes in Patients with Recurrent ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

38. AS-246: Safety and Efficacy of Subintimal Angioplasty in Patient with Chronic Total Occlusion Lesions in Iliofemoral Artery

39. AS-104: Impact of Statins on 12-Month Clinical Outcomes in Patients with Acute Non–ST-Segment Elevation Myocardial Infarction

40. AS-270: Impact of Coronary Stent Thrombosis on Clinical and Angiographic Outcomes in Patients undergoing Percutaneous Coronary Intervention with Drug Eluting Stents in an Asian Population

41. AS-88: Efficacy and Safety of Pitavastatin (Livalo) in Patients with Acute ST-Segment Elevation Myocardial Infarction: 12-Month Follow-Up Data from the Livalo Acute Myocardial Infarction Study (LAMIS)

42. AS-87: The Influence of Prior Myocardial Infarction on 12-Month Clinical Outcomes in Patients with Acute Non–ST-Segment Elevation Myocardial Infarction

43. AS-106: Impact of Statins on 12-Month Clinical Outcomes in Patients with Acute ST-Segment Elevation Myocardial Infarction

44. AS-48: Diabetic Foot Versus Nondiabetic Foot: Are There Different Outcomes Following Percutaneous Transluminal Angioplasty in Patients with Critical Limb Ischemia?

45. AS-188: Impact of Adjunctive Cilostazol on Midterm Clinical and Angiographic Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

46. AS-190: Impact of Age on Midterm Angiographic and Clinical Outcomes of Percutaneous Coronary Intervention with Drug-Eluting Stents in Patients with Alcoholism

47. AS-96: The 12-Month Clinical Outcomes of Acute ST-Segment Elevation Myocardial Infarction Versus Acute Non–ST-Segment Elevation Myocardial Infarction in Patients with Previous Acute Myocardial Infarction

48. AS-99: The Influence of Previous Myocardial Infarction on Clinical Characteristics and In-Hospital Outcomes in Patients with Recurrent Acute Myocardial Infarction

49. AS-246: Safety and Efficacy of Pitavastatin (Livalo) in Patients with Acute Myocardial Infarction in an Asian Population (Livalo-AMI Study; LAMIS)

50. AS-69: Drug-Eluting Stent versus Balloon Angioplasty in Small Target Vessels in Patients with Acute Myocardial Infarction

Catalog

Books, media, physical & digital resources